Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Johnson & Johnson (NY:JNJ)

165.84 +2.13 (+1.30%)
Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,481,447
Open 164.37
Bid (Size) 160.40 (1)
Ask (Size) 161.82 (1)
Prev. Close 163.71
Today's Range 164.23 - 166.63
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 2.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
Value stocks are outperforming flashy growth rivals due to market uncertainty, making value-based ETFs a good bet for steady income and diversification. 
Via Benzinga
Topics ETFs Economy
Exposures Economy Interest Rates
1 Healthcare Stock to Target This Week and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities

Performance

YTD
+15.2%
+15.2%
1 Month
+0.5%
+0.5%
3 Month
+15.7%
+15.7%
6 Month
+2.3%
+2.3%
1 Year
+5.1%
+5.1%

More News

Read More
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
3 Relatively Safe Stocks to Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Elliott Wave Technical Analysis: Johnson & Johnson - Friday, March 28
Via Talk Markets
Topics Stocks / Equities
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
2 Reasons to Like JNJ and 1 to Stay Skeptical
Via StockStory
Topics Supply Chain
Exposures Supply Chain
What Rare Earth Minerals Does Ukraine Have?
Via MarketMinute
Topics Economy Electric Vehicles Emissions
Exposures Economy Electric Vehicles Fossil Fuels
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Via Investor's Business Daily
Topics Government
Exposures Political
2 Recession-Proof Dividend Stocks to Buy and Hold
Via The Motley Fool
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
Via Benzinga
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?
Via Stocktwits
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Via Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
Via Benzinga
Exposures Product Safety
Johnson & Johnson To Invest $55 Billion In US To Boost Manufacturing, Drug Discovery
Via Benzinga
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
From Johnson & Johnson
Via Business Wire
Two Sectors Just Tried And Failed - And That’s Great For Us
Via Talk Markets
Topics Stocks / Equities
Historic Dividend Outperformance
Via Talk Markets
Topics ETFs Stocks / Equities
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
Via Benzinga
Honeywell Isn't Going to Let a Little Breakup Ruin Its Growth Plans
Via The Motley Fool
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
Via Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
Via Benzinga
Exposures Product Safety
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
Via Benzinga
Got $300? Buy These 3 Top Dividend Stocks and Never Look Back.
Via The Motley Fool
Resilient Investing: 3 Stocks Built to Weather Market Volatility
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 165.84
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 03/31/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 435.94B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 436B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.